Minneapolis Becomes First Large U.S. City to Allow Islamic Prayer Calls Over Speakers, by Jonah McKeownApril 19, 2023
Cupich Restricts Eucharistic Adoration, The PillarApril 19, 2023
The Supreme Court is expected to make an interim ruling this week on whether or not to temporarily limit the FDA’s approval of abortion drugs.
By David Bjornstrom, LifeSiteNews, Apr 18, 2023
David Bjornstrom is a retired California attorney and member of the U.S. Supreme Court bar. Nothing in this article is to be considered legal advice or an examination of the law or passing upon the legal effect of any act, document or law.
(LifeSiteNews) — Chemical abortions were more than half of all US abortions in 2020, possibly 60% or more now according to recent estimates. Federal court cases are pending in Texas and Washington relating to the validity of the FDA’s 2000 approval of the abortion drug mifepristone and the FDA’s 2016-2023 rule changes that loosened restrictions on chemical abortion procedures.
The Supreme Court will decide whether or not to roll back the FDA’s drastic post-2016 expansion of chemical abortions. This would be a temporary hold (“stay” order) until those issues can be litigated more fully in the lower courts. Or the Court could allow chemical abortions to continue as usual while the lower Courts do their job. …